The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000561381
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
16/04/2026
Date registered
Help: Date registered
4/05/2026
Date last updated
Help: Date last updated
11/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
4/05/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Public health physiotherapy pathways for anterior cruciate ligament injury
Scientific title
Public health physiotherapy pathways for anterior cruciate ligament injury: a three-arm pilot feasibility randomised controlled trial
Additional trial identifiers [1] 317031 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Anterior cruciate ligament injury 341529 0
Condition category
Condition code
Musculoskeletal 337604 337604 0 0
Other muscular and skeletal disorders
Physical Medicine / Rehabilitation 337605 337605 0 0
Physiotherapy
Injuries and Accidents 337737 337737 0 0
Other injuries and accidents

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Participants will be randomised (1:1:1) into one of three groups: i) usual care alone; ii) physiotherapist-led education in addition to usual care; and iii) physiotherapist-led education and supervised exercise-based rehabilitation in addition to usual care.

Arm 1 - Physiotherapist-led education in addition to usual care
Participants will attend a 30-to-45-minute dedicated education session aligning with best-practice recommendations for ACL injury care delivered by a physiotherapist experienced in delivering education content over videoconferencing (Zoom platform) using a standardised slide deck to ensure consistency across participants. The education session will provide evidence for ACL injury management and expected outcomes (emphasising the equivalent outcomes following surgery vs non-surgical rehabilitation) and will include structured, patient-centred discussion on several key topics. These include: understanding ACL injury and typical recovery trajectories (including the non-linear nature of recovery); comparison of treatment options (rehabilitation with or without surgery) and expected timelines for return to activity; the role and structure of progressive rehabilitation; indications for delayed ACL reconstruction (e.g., persistent instability despite adequate rehabilitation or concomitant injury); and the risks and potential complications associated with surgery. The session will also address psychological aspects of recovery (e.g., confidence, fear of re-injury, and expectations), and emphasise that commencing rehabilitation early and trialling exercise-based management does not compromise future surgical outcomes.
The education session is interactive and tailored to the participant’s goals, concerns, and stage of recovery, with a focus on empowering patients in their treatment decision-making process and when ACL reconstruction (ACLR) surgery is indicated. This once-off education session will be delivered on top of the usual care pathway provided (see control - ‘usual care’ group). Participants from this group will not be restricted from seeking further treatment. Indeed, the education content will emphasise the importance of trialling exercise-based rehabilitation but not be provided as part of the trial itself.

Arm 2 - Physiotherapist-led education and supervised exercise-based rehabilitation in addition to usual care
In addition to the ‘usual care’ described below and the dedicated education session described above, participants allocated to this group will be provided with supervised exercise-based rehabilitation at Eastern Health. Participants will undertake a supervised exercise program (based on best available evidence for ACL injury and codesigned with patient-partners and experienced physiotherapists) over a 6-month period delivered by a registered physiotherapist, which will support the transition to an unsupervised program beyond this period.

The rehabilitation program targets key domains of ACL recovery, including restoration of knee range of motion, quadriceps and lower-limb muscle strength, neuromuscular control, functional performance, and progressive return to sport and physical activity. Rehabilitation is structured across broad phases reflecting recovery progression: an acute phase (focused on reducing swelling, restoring range of motion, and activating quadriceps), an intermediate phase (focused on improving strength and neuromuscular control and introducing functional tasks), a late phase (focused on achieving high levels of strength and functional symmetry and progressing to sport-specific activities), and a maintenance phase (focused on long-term strength, load management, and injury prevention).

Progression through the program is criteria-based rather than time-based and is guided by symptom response (e.g., pain and swelling), movement quality, and functional performance (e.g., strength and hop test symmetry), as determined by the treating physiotherapist. Exercise prescription (type, intensity, and volume) will be individualised but typically includes resistance exercises (e.g., squatting, lunging, and step-based tasks), neuromuscular and balance training, and, in later stages, plyometric and agility-based exercises.

The sessions will be conducted weekly for the first 4 weeks, then fortnightly for 8 weeks, and monthly over the last 3 months, for a total of 11 sessions. They will last 30 to 60 minutes, depending upon participant capacity and abilities. To reduce barriers for participation, the physiotherapist-led sessions will be delivered in-person (Box Hill Hospital and/or Maroondah Hospital) or via videoconferencing (Eastern Health telehealth platform - healthdirect) (depending on patient preference and service availability), which have been shown to be equally effective. Appointment location and format (in-person or telehealth) will be determined collaboratively between the participant and the treating physiotherapist to optimise accessibility.

Participants will be encouraged to perform the exercise program up to 3 times per week (i.e., some weeks will be 3 home-based sessions and some weeks will be 2 home-based sessions and 1 supervised session). Exercise programs will be prescribed and progressed by a registered physiotherapist using an individualised, staged approach based on participant symptoms and functional capacity. For telehealth and home-based exercise, participants will receive clear verbal and written instructions, including safety guidance and progression criteria. Exercises will be modified as required based on participant response, and participants will be advised to stop exercises and contact the physiotherapist if they experience increased pain, swelling, instability, or other concerning symptoms. Regular monitoring will occur during supervised sessions (in-person or via telehealth), consistent with standard physiotherapy practice.

All participants will receive usual care. As per normal clinical care and previous ACL injury RCTs, participants randomised to the “Physiotherapist-led education and supervised exercise-based rehabilitation in addition to usual care” group who experience ACL insufficiency (i.e., ongoing instability and positive clinical testing on ACL deficient tests), and/or subsequently desire ACLR, will be encouraged to seek orthopaedic surgeon opinion as part of their usual care at Eastern Health, and if ACLR is performed, participants will receive usual postoperative care.

Given that participants may be enrolled in the study at various time-points following their injury (i.e., there is no specific eligibility criteria regarding time since injury), the education and supervised exercise components will be tailored to the stage of injury and recovery status. This fits into the pragmatic nature of this pilot trial.
Intervention code [1] 333788 0
Treatment: Other
Intervention code [2] 333789 0
Rehabilitation
Intervention code [3] 333790 0
Behaviour
Description of the comparator or control
Control - Usual care alone
Participants randomised to the ‘usual care alone’ group will receive routine care offered by Eastern Health following ACL injury. This varies from person to person and can depend on a number of factors (e.g., age, severity of injury, future goals). Usual care at Eastern Health typically involves an orthopaedic consultation to assess the knee and discuss management options. Depending on their individual situation, this may include referral to physiotherapy (hospital-based, community-based or private), advice on activity modification, and/or consideration of ACLR surgery. The type and timing of care will be determined by the treating healthcare team.
Control group
Active

Outcomes
Primary outcome [1] 345099 0
Feasibility of conducting a full-scale RCT, assessed as a composite of: - Protocol integrity (participant acceptability and completeness of outcome data) - Recruitment and retention (recruitment, eligibility, enrolment and drop-out rates) - Adherence to supervised and home-based exercise sessions - Adverse events (number and proportion of participants experiencing related adverse events during the study period)
Timepoint [1] 345099 0
6 and 12 months post-randomisation
Secondary outcome [1] 460489 0
ACL reconstruction surgery rate
Timepoint [1] 460489 0
6 and 12 months post-randomisation
Secondary outcome [2] 460490 0
Willingness for surgery
Timepoint [2] 460490 0
Baseline, 6 and 12 months post-randomisation
Secondary outcome [3] 460491 0
Treatment preference
Timepoint [3] 460491 0
Baseline, 6 and 12 months post-randomisation
Secondary outcome [4] 460492 0
Total Knee Injury and Osteoarthritis Outcome Score (KOOS4), one total score calculated as the average of four subscales (pain, symptoms, sport and recreation function, and quality of life). Each subscale scored from 0 to 100.
Timepoint [4] 460492 0
Baseline, 6 and 12 months post-randomisation
Secondary outcome [5] 460494 0
KOOS Pain
Timepoint [5] 460494 0
Baseline, 6 and 12 months post-randomisation
Secondary outcome [6] 460495 0
KOOS Symptoms
Timepoint [6] 460495 0
Baseline, 6 and 12 months post-randomisation
Secondary outcome [7] 460496 0
KOOS Sport and recreation function
Timepoint [7] 460496 0
Baseline, 6 and 12 months post-randomisation
Secondary outcome [8] 460497 0
KOOS Quality of life
Timepoint [8] 460497 0
Baseline, 6 and 12 months post-randomisation
Secondary outcome [9] 460498 0
Global rating of change
Timepoint [9] 460498 0
6 and 12 months post-randomisation
Secondary outcome [10] 460499 0
Satisfaction with current knee function
Timepoint [10] 460499 0
Baseline, 6 and 12 months post-randomisation
Secondary outcome [11] 460500 0
Return to pre-injury level of sport or activity
Timepoint [11] 460500 0
6 and 12 months post-randomisation

Eligibility
Key inclusion criteria
Adults aged 18-40 years referred to orthopaedics at Eastern Health with an imaging confirmed (magnetic resonance imaging) complete ACL rupture.
Minimum age
18 Years
Maximum age
40 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
i) concomitant injury with an indication for surgery (e.g. unstable, displaced meniscal tear [radial, bucket handle, posterolateral corner and/or posterior root tear], large [grade 2 or 3] medial collateral ligament tear, fracture);
ii) prior history of ACL rupture on same knee;
iii) already wait-listed for ACLR;
iv) unable to understand written or spoken English;
v) current state/national/international level athletes.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Randomisation is computer-generated and embedded within REDCap to ensure concealed allocation until assignment occurs.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Pre-generated blocked allocation sequence embedded within REDCap.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
Sample size:
As this is a pilot study to assess the feasibility to recruit patients, no formal power calculation is needed. We will aim to recruit as many participants as possible over a 6-month period or until we reach 30 total participants (approximately 10 per group). Randomisation will be undertaken using a pre-generated blocked allocation sequence embedded within REDCap, with a sequence generated beyond the target sample size to preserve allocation concealment. As a result, the final distribution across groups at a total sample of 30 may differ slightly (e.g., 9, 10, or 11 participants per group). This sample size strategy is based on previous pilot randomised controlled trials evaluating health professional–guided interventions for musculoskeletal conditions and is considered sufficient to estimate key feasibility parameters, including recruitment, adherence, and follow-up completion rates, and to inform the design and sample size calculation of a future definitive trial.

Statistical analysis plan:
All analyses will be primarily descriptive and focused on feasibility outcomes. Recruitment, eligibility, enrolment, adherence (supervised and home-based exercise), follow-up completion, and adverse events will be summarised using counts and proportions, with corresponding confidence intervals where appropriate. Continuous secondary outcomes (e.g., Knee Injury and Osteoarthritis Outcome Score) will be summarised using means and standard deviations or medians and interquartile ranges, as appropriate, at each timepoint.

Between-group comparisons will be exploratory and interpreted cautiously, given the pilot nature of the study and lack of statistical power. Estimates of between-group differences and corresponding confidence intervals will be reported to inform the design of a future trial, rather than formal hypothesis testing. Categorical outcomes will be summarised as proportions, and continuous outcomes as mean or median values over time.

All analyses will follow the intention-to-treat principle, including all participants as randomised where possible. No formal adjustment for multiplicity will be undertaken. Missing data will be described, and no formal imputation is planned for feasibility outcomes.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 29398 0
Eastern Health - Box Hill
Recruitment postcode(s) [1] 45719 0
3128 - Box Hill

Funding & Sponsors
Funding source category [1] 321626 0
Government body
Name [1] 321626 0
National Health and Medical Research Council Investigator Grant (GNT2008523)
Country [1] 321626 0
Australia
Funding source category [2] 322110 0
Commercial sector/Industry
Name [2] 322110 0
Medibank (Medibank Better Health Foundation)
Country [2] 322110 0
Australia
Primary sponsor type
University
Name
La Trobe University
Address
Country
Australia
Secondary sponsor category [1] 324447 0
None
Name [1] 324447 0
Address [1] 324447 0
Country [1] 324447 0
Other collaborator category [1] 283904 0
Government body
Name [1] 283904 0
Eastern Health
Address [1] 283904 0
Country [1] 283904 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320151 0
Eastern Health Human Research Ethics Committee
Ethics committee address [1] 320151 0
Ethics committee country [1] 320151 0
Australia
Date submitted for ethics approval [1] 320151 0
20/01/2026
Approval date [1] 320151 0
27/03/2026
Ethics approval number [1] 320151 0
E26-001-125597

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 149610 0
A/Prof Adam Culvenor
Address 149610 0
La Trobe Sport and Exercise Medicine Research Centre Health Science 3, La Trobe University, Kingsbury Drive, Bundoora, Victoria 3086
Country 149610 0
Australia
Phone 149610 0
+61 3 9479 5116
Fax 149610 0
Email 149610 0
Contact person for public queries
Name 149611 0
Adam Culvenor
Address 149611 0
La Trobe Sport and Exercise Medicine Research Centre Health Science 3, La Trobe University, Kingsbury Drive, Bundoora, Victoria 3086
Country 149611 0
Australia
Phone 149611 0
+61 3 9479 5116
Fax 149611 0
Email 149611 0
Contact person for scientific queries
Name 149612 0
Adam Culvenor
Address 149612 0
La Trobe Sport and Exercise Medicine Research Centre Health Science 3, La Trobe University, Kingsbury Drive, Bundoora, Victoria 3086
Country 149612 0
Australia
Phone 149612 0
+61 3 9479 5116
Fax 149612 0
Email 149612 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: For ethical reasons, individual data will not be publicly available.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.